Eyecyte-RPE phase 1 study showed promising safety and efficacy, with no serious adverse events and significant vision ...

The trial evaluates the safety and efficacy of Eyecyte-RPE in patients with geographic atrophy secondary to dry age-related ...

Improved axial resolution allows clearer visualization of early atrophic changes, including iRORA vs cRORA differentiation, ...

GA results in the gradual breakdown of retinal pigment epithelium (RPE) and light-sensitive cells, leading to vision impairment over time.Key Facts about Geographic Atrophy:- GA affects central ...

Serpiginous chorioretinopathy is a rare form of posterior uveitis that causes inflammation and subsequent atrophy of the choroid, RPE and retina. The disease typically starts near the optic nerve ...

- No intervention was shown to perform better for the treatment of central serous chorioretinopathy (CSC) than another. - Larger and higher-quality studies are needed to assess the benefits and ...

Boehringer Ingelheim has started a proof-of-concept trial of a drug that could offer the first oral treatment for geographic atrophy (GA ... pigment epithelial (RPE) cells in the central portion ...

The phase 1b trial will enrol patients with geographic atrophy secondary to age-related ... of photoreceptors and retinal pigment epithelial (RPE) cells in the central portion of the retina ...